Delayed Adoption of New Treatments in Developing World Costs Lives


Reducing the gap between the development of new drugs and treatments
and their implementation in the developing world could save thousands
of lives each day and make more effective use of the U.S. investment
in global health, according to scientists at the Fogarty International
Center, part of the National Institutes of Health.

Comments are closed.